Q1 EPS Estimates for Encompass Health Cut by Zacks Research

Encompass Health Co. (NYSE:EHC) – Stock analysts at Zacks Research dropped their Q1 2025 EPS estimates for shares of Encompass Health in a note issued to investors on Wednesday, January 8th. Zacks Research analyst Z. Masood now expects that the company will post earnings of $1.23 per share for the quarter, down from their previous estimate of $1.25. The consensus estimate for Encompass Health’s current full-year earnings is $4.29 per share. Zacks Research also issued estimates for Encompass Health’s Q2 2025 earnings at $1.21 EPS, FY2025 earnings at $4.73 EPS, Q1 2026 earnings at $1.33 EPS, Q3 2026 earnings at $1.23 EPS, Q4 2026 earnings at $1.30 EPS and FY2026 earnings at $5.27 EPS.

Other analysts also recently issued research reports about the stock. Truist Financial reissued a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp raised their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Royal Bank of Canada upped their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. UBS Group boosted their price objective on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Finally, Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $107.11.

Encompass Health Trading Down 1.9 %

NYSE:EHC opened at $91.08 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health has a one year low of $67.94 and a one year high of $104.55. The business’s 50-day simple moving average is $98.23 and its 200 day simple moving average is $93.78. The stock has a market cap of $9.18 billion, a price-to-earnings ratio of 22.00, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.86 earnings per share.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s payout ratio is 16.43%.

Institutional Trading of Encompass Health

Several large investors have recently added to or reduced their stakes in the business. UMB Bank n.a. grew its stake in shares of Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares in the last quarter. V Square Quantitative Management LLC grew its stake in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares during the last quarter. Avior Wealth Management LLC bought a new stake in shares of Encompass Health in the 3rd quarter worth approximately $40,000. Benjamin F. Edwards & Company Inc. lifted its stake in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after purchasing an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Encompass Health during the 2nd quarter worth $58,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.